Esperion Therapeutics, Inc. (ESPR)
2.72
-0.05
(-1.81%)
USD |
NASDAQ |
Mar 06, 16:00
2.725
0.00 (0.00%)
After-Hours: 20:00
Esperion Therapeutics Cash from Investing (TTM) : 0.00 for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Harrow, Inc. | -5.46M |
| Catalyst Pharmaceuticals, Inc. | -0.058M |
| Nektar Therapeutics | 58.64M |
| Rigel Pharmaceuticals, Inc. | -92.36M |
| AnaptysBio, Inc. | 228.03M |